Cargando…
Oseltamivir and baloxavir: Dual treatment for rapidly developing ARDS on a patient with renal disease
Influenza is an annual epidemic disease that in severe cases can lead to the development of ARDS. Current practice recommends the routine use of neuraminidase inhibitors with emerging evidence for the use of endonuclease inhibitors. We present the case of a 22-year-old female with diabetes and IgG4...
Autores principales: | Tobar Vega, Pool, Caldeira, Elena, Abad, Hasan, Saad, Peguy, Lachance, Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256313/ https://www.ncbi.nlm.nih.gov/pubmed/32489873 http://dx.doi.org/10.1016/j.idcr.2020.e00819 |
Ejemplares similares
-
Unusual presentation of pulmonary blastomycosis complicated by amphotericin-induced refractory electrolyte abnormalities
por: Tobar, Pool, et al.
Publicado: (2020) -
2645. Clinical Outcomes of Oseltamivir vs. Baloxavir in Patients Hospitalized with Influenza A
por: Shah, Sunish, et al.
Publicado: (2019) -
922. Cost-effectiveness of baloxavir marboxil versus oseltamivir or no treatment for the management of influenza in the United States
por: Hansen, Svenn, et al.
Publicado: (2023) -
1518. Real-World Comparative Effectiveness of Baloxavir Marboxil versus Oseltamivir on Influenza-Related Complication and Resource Utilization
por: Neuberger, Eddie, et al.
Publicado: (2020) -
Early Fever Resolution in Early Childhood Influenza Treated with Baloxavir Marboxil: A Retrospective Study Compared to Those with Oseltamivir
por: Nezu, Keiko, et al.
Publicado: (2023)